Cargando…

Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells

Plasmacytoid dendritic cells (pDCs) constitute a major source of type-I interferon (IFN-I) production during acute HIV infection. Their activation results primarily from TLR7-mediated sensing of HIV-infected cells. However, the interactions between HIV-infected T cells and pDCs that modulate this se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bego, Mariana G., Côté, Édouard, Aschman, Nick, Mercier, Johanne, Weissenhorn, Winfried, Cohen, Éric A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501562/ https://www.ncbi.nlm.nih.gov/pubmed/26172439 http://dx.doi.org/10.1371/journal.ppat.1005024

Ejemplares similares

Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction
por: Cao, Wei, et al.
Publicado: (2009)

Vpu and BST2: Still Not There Yet?
por: Sato, Kei, et al.
Publicado: (2012)

Mechanistic study of BST-2 down-modulation by HIV-1 Vpu
por: Zhang, Jianyong, et al.
Publicado: (2009)

Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice
por: Dave, Vibhuti P, et al.
Publicado: (2013)

Modulation of HIV-1-host interaction: role of the Vpu accessory protein
por: Dubé, Mathieu, et al.
Publicado: (2010)

2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation
por: Zhang, Quan, et al.
Publicado: (2016)

Conserved residues within the HIV-1 Vpu transmembrane-proximal hinge region modulate BST2 binding and antagonism
por: Lukhele, Sabelo, et al.
Publicado: (2017)

Plasmacytoid dendritic cell–specific receptor ILT7–FcɛRIγ inhibits Toll-like receptor–induced interferon production
por: Cao, Wei, et al.
Publicado: (2006)

Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2
por: Jia, Bin, et al.
Publicado: (2009)

The ESCRT-0 Component HRS is Required for HIV-1 Vpu-Mediated BST-2/Tetherin Down-Regulation
por: Janvier, Katy, et al.
Publicado: (2011)

HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment
por: Hauser, Heiko, et al.
Publicado: (2010)

HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment
por: Hauser, Heiko, et al.
Publicado: (2011)

Identification of novel key amino acids at the interface of the transmembrane domains of human BST-2 and HIV-1 Vpu
por: Pang, Xiaojing, et al.
Publicado: (2013)

Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence
por: Sugden, Scott M., et al.
Publicado: (2016)

The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu
por: Andrew, Amy J, et al.
Publicado: (2009)

High-Throughput NanoBiT-Based Screening for Inhibitors of HIV-1 Vpu and Host BST-2 Protein Interaction
por: Li, Boye, et al.
Publicado: (2021)

Identification of Residues in the BST-2 TM Domain Important for Antagonism by HIV-1 Vpu Using a Gain-of-Function Approach
por: Yoshida, Takeshi, et al.
Publicado: (2011)

Vpu Antagonizes BST-2–Mediated Restriction of HIV-1 Release via β-TrCP and Endo-Lysosomal Trafficking
por: Mitchell, Richard S., et al.
Publicado: (2009)

Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1
por: Jia, Xiaofei, et al.
Publicado: (2014)

βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin
por: Song, Yul Eum, et al.
Publicado: (2018)

Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum
por: Binette, Julie, et al.
Publicado: (2007)

HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2
por: Pham, Tram NQ, et al.
Publicado: (2014)

Antagonism of Tetherin Restriction of HIV-1 Release by Vpu Involves Binding and Sequestration of the Restriction Factor in a Perinuclear Compartment
por: Dubé, Mathieu, et al.
Publicado: (2010)

HIV-1 Vpu Neutralizes the Antiviral Factor Tetherin/BST-2 by Binding It and Directing Its Beta-TrCP2-Dependent Degradation
por: Mangeat, Bastien, et al.
Publicado: (2009)

Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses
por: Prévost, Jérémie, et al.
Publicado: (2019)

Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance
por: ZHANG, YI, et al.
Publicado: (2012)

Plasmacytoid Dendritic Cells in Atherosclerosis
por: Döring, Yvonne, et al.
Publicado: (2012)

Plasmacytoid dendritic cells in dermatology()()
por: Dias de Oliveira, Natasha Favoretto, et al.
Publicado: (2021)

Plasmacytoid dendritic cell neoplasms
por: Lee, Yoo Jin, et al.
Publicado: (2023)

Cryo-electron Microscopy Structure of the Native Prototype Foamy Virus Glycoprotein and Virus Architecture
por: Effantin, Grégory, et al.
Publicado: (2016)

A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2
por: Mi, Zeyun, et al.
Publicado: (2015)

A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing
por: Cella, Marina, et al.
Publicado: (1997)

Blastic plasmacytoid dendritic cell neoplasm
por: Lencastre, André, et al.
Publicado: (2013)

Blastic plasmacytoid dendritic cell neoplasm
por: Rai, Manoj Ponadka, et al.
Publicado: (2018)

Disease-Associated Plasmacytoid Dendritic Cells
por: Li, Shuang, et al.
Publicado: (2017)

The Role of Plasmacytoid Dendritic Cells in Cancers
por: Zhou, Binhui, et al.
Publicado: (2021)

Plasmacytoid Dendritic Cells and Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2022)

The transmembrane domain of HIV-1 Vpu is sufficient to confer anti-tetherin activity to SIVcpz and SIVgor Vpu proteins: cytoplasmic determinants of Vpu function
por: Kluge, Silvia F, et al.
Publicado: (2013)

Gag-Vpu cross talk modulating HIV-1 envelope incorporation and infectivity in cell-type dependent manner
por: Gautam, Archana, et al.
Publicado: (2012)

Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary
por: Schwich, Esther, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1pd9e099814jgaqhgqo8ssvts2